Toggle Main Menu Toggle Search

ePrints

Browsing publications by Professor Philip Home

Newcastle AuthorsTitleYearFull text
Professor Philip Home
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes2018
Professor Philip Home
Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes2018
Professor Philip Home
Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study2018
Professor Philip Home
Comment on Novodvorsky et al. Diurnal Differences in Risk of Cardiac Arrhythmias During Spontaneous Hypoglycemia in Young People With Type 1 Diabetes. Diabetes Care 2017;40:655–6622018
Professor Philip Home
Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)2018
Professor Philip Home
Need for regulatory change to incorporate beyond A1C glycemic metrics2018
Professor Philip Home
A diabetes mellitus guideline gone wrong - the 2017 ACP update2017
Professor Philip Home
Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events2017
Professor Philip Home
Comment on Abd El Aziz et al., A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients2017
Professor Philip Home
Comment on Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems 2005–2011. Diabetes Care 2016: 39; 363–3702017
1234567891011121314151617181920...